Cholesterol metabolism and non-cholesterol sterol distribution in lipoproteins of type 1 diabetes: The effect of improved glycemic control

Atherosclerosis

Volumn 194, Issue 2, 2007, Pages 465-472

  Sittiwet, Chaiyasit ^a,b   Gylling, Helena ^c   Hallikainen, Maarit ^c   Pihlajamäki, Jussi ^c   Moilanen, Leena ^c   Laaksonen, David E ^c   Niskanen, Leo ^c   Ågren, Jyrki J ^c   Laakso, Markku ^c   Miettinen, Tatu A ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b MAHASARAKHAM UNIVERSITY   (Thailand)

^c UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Cholestanol; Cholesterol absorption; Cholesterol synthesis; Chylomicrons; Lathosterol; Lipoproteins; Type 1 diabetes

Indexed keywords

CHOLESTANOL; CHOLESTEROL; CHOLESTEROL ESTER; CHYLOMICRON; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; INSULIN; INTERMEDIATE DENSITY LIPOPROTEIN; LATHOSTEROL; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; VERY LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; BLOOD ANALYSIS; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL ESTERIFICATION; CHOLESTEROL METABOLISM; CHOLESTEROL SYNTHESIS; CLINICAL ARTICLE; DIABETIC PATIENT; FEMALE; FOLLOW UP; GAS LIQUID CHROMATOGRAPHY; GLYCEMIC CONTROL; HEMOGLOBIN DETERMINATION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LIPID ANALYSIS; MALE; PRIORITY JOURNAL; SEPARATION TECHNIQUE; THIN LAYER CHROMATOGRAPHY; TREATMENT OUTCOME;

ADULT; BLOOD GLUCOSE; CHOLESTANOL; CHOLESTEROL; DIABETES MELLITUS, TYPE 1; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LIPOPROTEINS; MALE;

EID: 34848846093     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2006.08.044     Document Type: Article

References (42)

1. Dahl-Jørgensen K., Larsen J.R., and Hanssen K.F. Atherosclerosis in childhood and adolescent type 1 diabetes: early disease, early treatment?. Diabetologia 48 (2005) 1445-1453
2. Soedamah-Muthu S.S., Fuller J.H., Mulnier H.E., Raleigh V.S., Lawrenson R.A., and Colhoun H.M. High risk of cardiovascular disease in patients with type 1 diabetes in the U.K.: a cohort study using the general practice research database. Diabetes Care 29 (2006) 798-804
3. Roper N.A., Bilous R.W., Kelly W.F., Unwin N.C., and Connolly V.M. Cause-specific mortality in a population with diabetes: South Tees Diabetes Mortality Study. Diabetes Care 25 (2002) 43-48
4. American Diabetes Association. Management of dyslipidemia in children and adolescents with diabetes. Diabetes Care 26 (2003) 2194-2197
5. Orchard T.J., Olson J.C., Erbey J.R., et al. Insulin resistance-related factors, but not glycemia, predict coronary artery disease in type 1 diabetes: 10-year follow-up data from Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes Care 26 (2003) 1374-1379
6. Maahs D.M., Maniatis A.K., Nadeau K., Wadwa R.P., McFann K., and Klingensmith G.J. Total cholesterol and high-density lipoprotein levels in pediatric subjects with type 1 diabetes mellitus. J Pediatr 147 (2005) 544-546
7. Howard B.V. Lipoprotein metabolism in diabetes mellitus. J Lipid Res 28 (1987) 613-628
8. Rivellese A., Riccardi G., Romano G., et al. Presence of very low density lipoprotein compositional abnormalities in type 1 (insulin-dependent) diabetic patients; effects of blood glucose optimisation. Diabetologia 31 (1988) 884-888
9. Winocour P.H., Durrington P.N., Bhatnagar D., Ishola M., Arrol S., and Mackness M. Abnormalities of VLDL, IDL, and LDL characterize insulin-dependent diabetes mellitus. Arterioscler Thromb 12 (1992) 920-928
10. Pérez A., Caixàs A., Carreras G., et al. Lipoprotein compositional abnormalities in type I diabetes: effect of improved glycaemic control. Diabetes Res Clin Pract 36 (1997) 83-90
11. Andersen E., Hellström P., and Hellström K. Cholesterol and bile acid metabolism in middle-aged diabetics. Diabete Metab 12 (1986) 261-267
12. Gylling H., and Miettinen T.A. Cholesterol absorption and cholesterol and bile acid synthesis in two brothers with IDDM and diarrhoea. Diabetes Care 17 (1994) 1345-1347
13. Kojima H., Hidaka H., Matsumura K., et al. Effect of glycemic control on plasma plant sterol levels and post-heparin diamine oxidase activity in type 1 diabetic patients. Atherosclerosis 145 (1999) 389-397
14. Miettinen T.A., Gylling H., Tuominen J., Simonen P., and Koivisto V. Low synthesis and high absorption of cholesterol characterize type 1 diabetes. Diabetes Care 27 (2004) 53-58
15. Gylling H., Tuominen J.A., Koivisto V.A., and Miettinen T.A. Cholesterol metabolism in type 1 diabetes. Diabetes 53 (2004) 2217-2222
16. Järvisalo M, Raitakari O, Gylling H, Miettinen TA. Cholesterol absorption and synthesis in children with type 1 diabetes. Diabetes Care, in press.
17. Miettinen T.A. Detection of changes in human cholesterol metabolism. Ann Clin Res 2 (1970) 300-320
18. Gylling H., and Miettinen T.A. Serum noncholesterol sterols related to cholesterol metabolism in familial hypercholesterolemia. Clin Chim Acta 178 (1988) 41-50
19. Miettinen T.A., Tilvis R.S., and Kesäniemi Y.A. Serum plant sterols and cholesterol precursors reflect cholesterol absorption and synthesis in volunteers of a randomly selected male population. Am J Epidemiol 131 (1990) 20-31
20. Miettinen T.A., Tilvis R.S., and Kesäniemi Y.A. Serum cholestanol and plant sterol levels in relation to cholesterol metabolism in middle-aged men. Metabolism 38 (1989) 136-140
21. Havel R.J., Eder H.A., and Bragdon J.H. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 34 (1955) 1345-1353
22. Miettinen T.A. Cholesterol metabolism during ketoconazole treatment in man. J Lipid Res 29 (1988) 43-51
23. Miettinen T.A., and Gylling H. Cholesterol absorption efficiency with sterol metabolism in obesity. Atherosclerosis 153 (2000) 241-248
24. Simonen P., Gylling H., Howard A.N., and Miettinen T.A. Introducing a new component of the metabolic syndrome: low cholesterol absorption. Am J Clin Nutr 72 (2000) 82-88
25. Simonen P.P., Gylling H.K., and Miettinen T.A. Diabetes contributes to cholesterol metabolism regardless of obesity. Diabetes Care 25 (2002) 1511-1515
26. Simonen P.P., Gylling H., and Miettinen T.A. Body weight modulates cholesterol metabolism in non-insulin dependent type 2 diabetes. Obes Res 10 (2002) 328-335
27. Pihlajamäki J., Gylling H., Miettinen T.A., and Laakso M. Insulin resistance is associated with increased cholesterol synthesis and decreased cholesterol absorption in normoglycemic men. J Lipid Res 45 (2003) 507-512
28. Bloks V.W., Bakker-Van Waarde W.M., Verkade H.J., et al. Down-regulation of hepatic and intestinal Abcg5 and Abcg8 expression associated with altered sterol fluxes in rats with streptozotocin-induced diabetes. Diabetologia 47 (2004) 104-112
29. Glueck C.J., Speirs J., Tracy T., Streicher P., Illig E., and Vandegrift J. Relationships of serum plant sterols (phytosterols) and cholesterol in 595 hypercholesterolemic subjects, and familial aggregation of phytosterols, cholesterol, and premature coronary heart disease in hyperphytosterolemic probands and their first-degree relatives. Metabolism 40 (1991) 842-848
30. Gylling H., and Miettinen T.A. Cholesterol absorption and lipoprotein metabolism in type II diabetes mellitus without and with coronary artery disease. Atherosclerosis 126 (1996) 325-332
31. Sutherland W.H.F., Williams M.J.A., Nye E.R., Restieaux N.J., de Jong S.A., and Walker H.L. Associations of plasma noncholesterol sterol levels with severity of coronary artery disease. Nutr Metab Cardiovasc Dis 8 (1998) 386-391
32. Rajaratnam R.A., Gylling H., and Miettinen T.A. Independent association of serum squalene and noncholesterol sterols with coronary artery disease in postmenopausal women. J Am Coll Cardiol 35 (2000) 1185-1191
33. Sudhop T., Gottwald B.M., and von Bergmann K. Serum plant sterols as a potential risk factor for coronary heart disease. Metabolism 51 (2002) 1519-1521
34. Assmann G., Cullen P., Erbey J., Ramey D.R., Kannenberg F., and Schulte H. Plasma sitosterol elevations are associated with an increased incidence of coronary events in men: results of a nested case-control analysis of the Prospective Cardiovascular Münster (PROCAM) study. Nutr Metab Cardiovasc Dis 16 (2006) 13-21
35. Rajaratnam R.A., Gylling H., and Miettinen T.A. Cholesterol absorption, synthesis, and fecal output in postmenopausal women with and without coronary artery disease. Arterioscler Thromb Vasc Biol 21 (2001) 1650-1655
36. Miettinen T.A., Gylling H., Strandberg T., and Sarna S. Baseline serum cholestanol as predictor of recurrent coronary events in subgroup of Scandinavian simvastatin survival study. Finnish 4S investigators. BMJ 316 (1998) 1127-1130
37. Ballantyne C.M., Olsson A.G., Cook T.J., Mercuri M.F., Pedersen T.R., and Kjekshus J. Influence of low high-density lipoprotein cholesterol and elevated triglyceride on coronary heart disease events and response to simvastatin therapy in 4S. Circulation 104 (2001) 3046-3051
38. Ketomäki A., Gylling H., Siimes M.A., Vuorio A., and Miettinen T.A. Squalene and noncholesterol sterols in serum and lipoproteins of children with and without familial hypercholesterolemia. Pediatr Res 53 (2003) 648-653
39. Miettinen T.A. Serum methyl sterols and their distribution between major lipoprotein fractions in different clinical conditions. Ann Clin Res 3 (1971) 264-271
40. Koivisto P.V.I., and Miettinen T.A. Increased amounts of cholesterol precursors in lipoproteins after ileal exclusion. Lipids 23 (1988) 993-996
41. Strandberg T.E., Tilvis R.S., and Miettinen T.A. Metabolic variables of cholesterol during squalene feeding in humans: comparison with cholestyramine treatment. J Lipid Res 31 (1990) 1637-1643
42. Simonen PP, Gylling H, Miettinen TA. The distribution of squalene and non-cholesterol sterols in lipoproteins in type 2 diabetes. Atherosclerosis 2006, in press.